Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
J Eur Acad Dermatol Venereol ; 34 Suppl 6: 10-16, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32783264

RESUMEN

BACKGROUND: In patients with psoriasis, the non-lesional skin also presents abnormalities, requiring emollient application on the whole body. OBJECTIVES: To evaluate the tolerance of a new emollient balm containing celastrol, an active ingredient with anti-Th17 immunomodulatory properties used alone or in association with topical or systemic drug treatments or phototherapy, and its efficacy when used alone. METHODS: Adults with body plaque psoriasis applied the product over the whole body once a day for 4 weeks (balm used alone in 41 patients and with ongoing treatment in 50 patients). At D1, D8 ('balm alone' study) or D15 ('balm in association' study) and D29, the dermatologist rated physical and functional signs and assessed pruritus and body global lesion score (evaluating erythema, induration/thickness, scaling and dryness) in the 'balm alone' study. RESULTS: No reaction related to the product was reported, and the tolerance was deemed excellent. In the 'balm alone' study, mean pruritus intensity score significantly decreased at D8 (-39%, P < 0.001) and D29 (-60%, P < 0.001) compared with D1, together with the body global lesion score (-24% at D8 and -26% at D29, P < 0.001). In parallel, quality of life improved, as evidenced by a patient-reported outcome questionnaire. Cosmetic acceptability was good. CONCLUSION: This new emollient balm was very well tolerated by patients with body plaque psoriasis either alone or in association with drug treatment or phototherapy, which is important to ensure long-term compliance. Daily application during one month improved pruritus, physical signs and quality of life.


Asunto(s)
Triterpenos Pentacíclicos , Psoriasis , Triterpenos , Adulto , Humanos , Triterpenos Pentacíclicos/uso terapéutico , Psoriasis/tratamiento farmacológico , Calidad de Vida , Resultado del Tratamiento , Triterpenos/uso terapéutico
2.
Ann Dermatol Venereol ; 146(11): 696-703, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31558291

RESUMEN

Congenital syphilis (CS) is caused by Treponema pallidum infection in utero. There is a need to develop new tools to diagnose CS: the diagnostic value of PCR is difficult to assess. The aim of this study was to describe the clinical and laboratory characteristics of mothers and infants with CS as diagnosed by PCR tests on various maternal and neonatal samples. PATIENTS AND METHODS: We included all infants epidemiologically linked to a mother diagnosed with syphilis whose samples were referred to the Syphilis Reference Center, and for whom at least one positive PCR result was obtained. RESULTS: Twenty-two mother-infant pairs (8.3%) with assay performed on samples from one to four different anatomic sites were included between February 2011 and April 2018. Seven mothers (31.8%) were born abroad, fifteen (68.2%) presented psychological and/or social problems, eight (36.4%) had not been screened for syphilis prior to delivery, and eleven (50%) were referred from French overseas departments or territories, or from the Paris region. Six infants (27.3%) were stillborn and six were born preterm, while fifteen infants (68.2%) presented clinical features of CS. All infants born preterm were symptomatic. Infant VDRL/RPR titer was no greater than four times that in the mother's serum, except in two cases. DISCUSSION: Lack of antenatal care, social disadvantage and psychological issues were common. There is a need for enhanced surveillance both in the French overseas departments/territories and in the Paris region. A larger study is required to assess the sensitivity and specificity of PCR. The best site for sampling has yet to be established. We recommend the collection of as many samples as possible to avoid underdiagnosis of CS.


Asunto(s)
ADN Bacteriano , Reacción en Cadena de la Polimerasa , Sífilis Congénita/diagnóstico , Treponema pallidum/genética , Adolescente , Adulto , Femenino , Francia , Humanos , Lactante , Recién Nacido , Recien Nacido Prematuro , Embarazo , Estudios Prospectivos , Mortinato , Adulto Joven
3.
J Eur Acad Dermatol Venereol ; 31 Suppl 6: 3-18, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28805934

RESUMEN

'Fragile skin', or skin with lower resistance to aggressors, can be broadly classified into four causal categories: constitutional (age-dependent or associated with specific vulnerable locations on the body, e.g. eyelids), pathological (related to disease), circumstantial (related to environmental or internal factors, e.g. stress) and iatrogenic (caused by medical interventions or treatments). In this supplement, we focus on the fourth category, the iatrogenic origin of fragile skin and the role that dermo-cosmetics can have in restoring the natural protective function of the skin following treatments for skin diseases and medical interventions. We present epidemiological data on the prevalence of fragile skin in three different geographical regions, and the results of two randomized controlled studies investigating the efficacy and tolerability of dermo-cosmetics in combination with topical acne treatment and following physical skin damage. Overall, we found that prevalence across the three regions (23% in Germany, 41% in UAE, 56% in Taiwan) reflected previous global estimates (24-53%) across skin types, with significant associations found with environmental and lifestyle factors, such as stress, humidity and pollution. The iatrogenic effects of topical acne treatments can result in poor compliance or use of over-the-counter moisturizers, which may reduce treatment efficacy. Dermo-cosmetics were found to aid in restoration of fragile skin caused by the acne topical retinoid treatment adapalene 0.1% gel, by reducing transepidermal water loss and improving skin hydration, as well as reducing the side-effects such as skin irritation that are frequently associated with topical retinoids. Additionally, dermo-cosmetic products were found to accelerate wound closure following skin damage in a laser ablation model and reduced the duration of post-procedural side-effects such as itching and burning.


Asunto(s)
Acné Vulgar/tratamiento farmacológico , Fármacos Dermatológicos/uso terapéutico , Epidermis/patología , Administración Tópica , Adolescente , Adulto , Cosméticos , Estudios Transversales , Fármacos Dermatológicos/administración & dosificación , Fármacos Dermatológicos/efectos adversos , Femenino , Humanos , Masculino , Adulto Joven
4.
J Eur Acad Dermatol Venereol ; 30 Suppl 4: 3-56, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27062556

RESUMEN

Within their first days of life, newborns' skin undergoes various adaptation processes needed to accommodate the transition from the wet uterine environment to the dry atmosphere. The skin of newborns and infants is considered as a physiological fragile skin, a skin with lower resistance to aggressions. Fragile skin is divided into four categories up to its origin: physiological fragile skin (age, location), pathological fragile skin (acute and chronic), circumstantial fragile skin (due to environmental extrinsic factors or intrinsic factors such as stress) and iatrogenic fragile skin. Extensive research of the past 10 years have proven evidence that at birth albeit showing a nearly perfect appearance, newborn skin is structurally and functionally immature compared to adult skin undergoing a physiological maturation process after birth at least throughout the first year of life. This article is an overview of all known data about fragility of epidermis in 'fragile populations': newborns, children and adolescents. It includes the recent pathological, pathophysiological and clinical data about fragility of epidermis in various dermatological diseases, such as atopic dermatitis, acne, rosacea, contact dermatitis, irritative dermatitis and focus on UV protection.


Asunto(s)
Epidermis/fisiología , Adaptación Fisiológica , Adolescente , Células Cultivadas , Niño , Células Epidérmicas , Humanos , Recién Nacido , Queratinocitos/citología
5.
Parassitologia ; 39(4): 279-83, 1997 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9802080

RESUMEN

We used a model of acquired toxoplasmosis to study the immune response in pregnant BALB/c mice (IL-4+/+) and in pregnant transgenic IL-4-deficient BALB/c mice (IL-4-/-) during acute toxoplasmosis. Female BALB/c mice were infected orally by 20 tissue cysts of the avirulent PRU strain of Toxoplasma gondii on day 11 of pregnancy. Splenocyte cultures were used to explore proliferative responses and cytokine production in vitro. Parasite loads were determined in the lungs on day 7 post-infection and in the brain on day 30 post-infection. After infection, cultured spleen cells from pregnant mice produced more IFN-gamma (a Type I cytokine) and more NO than non pregnant mice, and the Type 2 response (IL-4 and IL-10) was weak. Although this kind of immune response may be required for mice to recover from toxoplasmosis, pregnant mice were more susceptible to infection than non pregnant mice, as illustrated by a larger parasite load in lungs and brain. Pregnant IL-4-/- mice showed lower susceptibility to T. gondii infection and a lower materno-fetal transmission rate (24% vs. 53% infected fetuses) without increased production of Type I cytokines (IFN-gamma and NO). These data indicate that Type 2 response plays an important role in increasing mouse susceptibility to T. gondii infection during pregnancy and that IL-4 and pregnancy-associated substances increase the transplacental passage of T. gondii.


Asunto(s)
Interleucina-4/fisiología , Complicaciones Infecciosas del Embarazo/inmunología , Toxoplasmosis Animal/inmunología , Animales , Encéfalo/parasitología , Susceptibilidad a Enfermedades , Femenino , Interleucina-4/deficiencia , Pulmón/parasitología , Activación de Linfocitos , Linfocinas/metabolismo , Intercambio Materno-Fetal , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Óxido Nítrico/fisiología , Placenta/inmunología , Placenta/parasitología , Embarazo , Complicaciones Infecciosas del Embarazo/psicología , Bazo/citología , Células TH1/inmunología , Células TH1/metabolismo , Células Th2/inmunología , Células Th2/metabolismo , Toxoplasma/aislamiento & purificación , Toxoplasma/fisiología , Toxoplasmosis Animal/congénito , Toxoplasmosis Animal/transmisión , Toxoplasmosis Cerebral/inmunología
6.
Ann Biol Clin (Paris) ; 55(5): 460-4, 1997.
Artículo en Francés | MEDLINE | ID: mdl-9347014

RESUMEN

We used a model of acquired toxoplasmosis to study the immune response in pregnant BALB/c mice (IL4+/+) and in pregnant transgenic IL4-deficient BALB/c mice (IL4-/-) during acute toxoplasmosis. Female BALB/c mice were infected orally by 20 tissue cysts of the avirulent PRU strain of Toxoplasma gondii on day 11 of pregnancy. After infection, cultured spleen cells from pregnant mice produced more IFN gamma (a type 1 cytokine) and more NO than non pregnant mice, and the type 2 response (IL4 and IL10) was weak. Although this kind of immune response may be required for mice to recover from toxoplasmosis, pregnant mice were more susceptible to infection than non pregnant mice, as illustrated by a larger parasite load in lungs and brain. Pregnant IL4-/- mice showed lower susceptibility to T. gondii infection and a lower materno-fetal transmission rate (24% versus 53% infected fetus) without increased production of type 1 cytokines (IFN gamma and NO). These data indicate that type 2 response plays an important role in increasing mouse susceptibility to T. gondii infection during pregnancy and that IL4 and pregnancy-associated substances increase the transplacental passage of T. gondii. This is the first time that biased towards type 2 immune response induced by pregnancy was shown to increase susceptibility to T. gondii.


Asunto(s)
Modelos Animales de Enfermedad , Toxoplasmosis Animal/congénito , Toxoplasmosis Animal/inmunología , Animales , Formación de Anticuerpos , Femenino , Inmunidad Celular , Interferón Tipo I/metabolismo , Interferón gamma/metabolismo , Interleucina-4/genética , Ratones , Ratones Endogámicos BALB C , Ratones Transgénicos , Óxido Nítrico/metabolismo , Embarazo , Toxoplasmosis Animal/genética , Toxoplasmosis Animal/metabolismo
7.
Ann Biol Clin (Paris) ; 58(4): 417-24, 2000.
Artículo en Francés | MEDLINE | ID: mdl-10932041

RESUMEN

Leukoagglutination is a rare EDTA-dependent phenomenon resulting in a spurious minoration of the leukocyte count performed using automated analyzers. We described seven cases. The leukocyte agglutination was detected by unstable WBC count, abnormal WBC histograms and presence of clusters of polymorphonuclears on the smear. PMN aggregates of 3 to 10 cells or bigger were observed. Discrepancies between the erroneous automated WBC count and the real count were moderate in most cases. Leukoagglutination was related to lymphoproliferative disorders, infections, alcoholic liver diseases, auto-immune diseases. Inflammatory context seemed to be requested. For few patients, the artefact occurred regardless of the type of anticoagulants (lithium heparin, buffered sodium citrate) and warming at 37 C did not always increase the WBC. Dilution in Unopette chambers was required. We confirmed that leukoagglutination of PMN was an in vitro artefact EDTA and/or temperature mediated.


Asunto(s)
Artefactos , Recuento de Leucocitos , Leucocitos/fisiología , Leucopenia/diagnóstico , Neutrófilos/fisiología , Aglutinación , Ácido Edético , Humanos , Laboratorios , Leucopenia/sangre , Reproducibilidad de los Resultados
10.
Br J Clin Pharmacol ; 13(4): 533-7, 1982 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-6121577

RESUMEN

1 Diacetolol is the N-acetylated metabolite of acebutolol and possesses beta-adrenergic receptor blocking properties. 2 Its antihypertensive action was assessed in accordance with a double-blind randomised cross-over scheme in 17 patients with moderate essential hypertension previously well controlled with acebutolol. 3 Significant reductions in lying mean arterial blood pressure were observed with daily doses of 200 mg (- 9%), 400 mg (- 10%) and 800 mg (- 14%), and were associated with significant decreases in heart rate and plasma renin activity. 4 The diacetolol mean plasma level measured 8 to 10 h after drug ingestion was proportional to the dose (207 +/- 27, 394 +/- 63 and 823 +/- 135 ng/ml for respectively 200, 400 and 800 mg/day).


Asunto(s)
Acebutolol/análogos & derivados , Antagonistas Adrenérgicos beta/uso terapéutico , Hipertensión/tratamiento farmacológico , Acebutolol/efectos adversos , Acebutolol/uso terapéutico , Antagonistas Adrenérgicos beta/efectos adversos , Adulto , Anciano , Presión Sanguínea/efectos de los fármacos , Ensayos Clínicos como Asunto , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Factores de Tiempo
11.
Biofouling ; 19(3): 177-86, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-14619286

RESUMEN

To produce ecological marine paints, it is necessary to understand the phenomena involved in antifouling activity. Due to the multivariable components which have to be taken into account and due to their analytical intricacy, only studies based on selected properties are conceivable. In this study, four properties have been chosen, viz. erosion, biocide release, roughness and the physicochemical characteristics of the film surface. A principal-component analysis (PCA) of the experimental data has shown that, among the selected properties, only erosion affected antifouling efficiency. A more detailed investigation of erosion by quantifying global hydration and hydrolysis of immersed paints revealed the difficulty in linking the chemical structure of binders to the final erosion properties. Biocide release from paints, quantified by chromatographic methods coupled with UV detection, was inferior to the doses stated by the paint producers. These observations allowed the conceiving of formulations with reduced amounts of active molecules. The development of erodable, biodegradable binders associated with non toxic compounds is a promising way to obtain efficient antifouling paints compatible with existing, preventive systems.


Asunto(s)
Pintura/análisis , Plaguicidas/toxicidad , Cromatografía Líquida de Alta Presión , Pintura/toxicidad , Polímeros/química , Análisis de Componente Principal , Propiedades de Superficie
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda